Medplus Health Services Ltd

NSE: MEDPLUS · BSE: 543427 · Healthcare · 93 announcements

Share price: ₹647.30
Market cap: ₹7,776 Cr
Revenue (annual): ₹6,892 Cr
Net profit (annual): ₹219.7 Cr
P/E (TTM): 37.0×Sector 53.1×
Promoter holding: 40.19%-0.03% QoQ
FII holding: 14.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Adverse Business Impact 42 Legal & Regulatory 17 Earnings Call 5 Other Announcement 4 Management Change 4 Board Meeting Outcome 4 Board Meeting Date 3 Share Pledge 2 Financial Results 2 Capital Structure Change 2 Business Update 2 Annual General Meeting 2 Employee Stock Options 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

91 announcements with these filters

9 Apr 2026 18:05 IST NSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

MedPlus subsidiary Optival Health Solutions received a two-day drug license suspension order for a store in Jadcherla, Telangana. The suspension, effective from April 8, 2026, carries a negligible estimated revenue loss of ₹0.28 lacs (approximately ₹0.00 Crore) and follows alleged violations of the Drugs and Cosmetics Act, 1940.

Execution: 2 days

Read the filing ↗